Evidence map›Paper›PMID 39325584›Full record

ArticleDiabetes2024

Role of Sec61α2 Translocon in Insulin Biosynthesis.

Xiaoxi Xu, Thomas W Bell, Truc Le, Ivy Zhao, Emily Walker, Yiqing Wang, Ning Xu, Scott A Soleimanpour, Holger A Russ, Ling Qi and 3 more

Abstract read
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaoxi XuDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.
Thomas W BellDepartment of Chemistry, University of Nevada, Reno, NV.
Truc LeDepartment of Chemistry, University of Nevada, Reno, NV.
Ivy ZhaoDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.
Emily WalkerDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.
Yiqing WangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Ning XuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Scott A SoleimanpourDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.
Holger A RussDiabetes Institute, University of Florida College of Medicine, Gainesville, FL.
Ling QiDepartment of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA.
Billy TsaiDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI.
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-4007-8799

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Soleimanpour · 2013 to 2026
$24.3M
Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN).U24DK104162 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI John S. Kaddis, Joyce Carol Niland · 2019 to 2026
$12.3M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + SecretionR01DK111174 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARVAN, PETER, QI, LING · 2016 to 2024
$5.5M
A Stress-Induced Vicious Cycle In The Development of T1DU01DK127747 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARVAN, PETER, SATIN, LESLIE S. · 2020 to 2023
$2.8M
Local immune modulation for beta cell replacement therapy in type 1 diabetesR01DK132387 · NIDDK · UNIVERSITY OF FLORIDA · PI PHELPS, EDWARD, RUSS, HOLGER A. · 2022 to 2025
$2.1M
Elucidating how transcription factors MAFA and MAFB and mitochondrial activity control human β cell identity and functionK01DK133533 · NIDDK · WAYNE STATE UNIVERSITY · PI Emily M Walker · 2023 to 2026
$596k
Small-molecule Inhibitors of Human CD4 ExpressionR15GM120659 · NIGMS · UNIVERSITY OF NEVADA RENO · PI BELL, THOMAS W. · 2016 to 2016
$423k
Development of a Novel Inhibitor for Hepatitis BR21AI154254 · NIAID · UNIVERSITY OF NEVADA RENO · PI BELL, THOMAS W. · 2020 to 2021
$385k
Breakthrough T1DNational Key R&D Program 2019YFA0802502National Natural Science Foundation of China 82000796NIAID NIH HHS R21 AI154254NIDDK NIH HHS K01 DK133533NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK111174NIDDK NIH HHS R01 DK12044NIDDK NIH HHS R01 DK132387NIDDK NIH HHS U01 DK127747NIDDK NIH HHS U24 DK104162NIGMS NIH HHS R15 GM120659NIH HHS K01 DK133533
6 · The paper itself

Abstract

Translocational regulation of proinsulin biosynthesis in pancreatic β-cells is unknown, although several studies have reported an important accessory role for the Translocon-Associated Protein complex to assist preproinsulin delivery into the endoplasmic reticulum via the heterotrimeric Sec61 translocon (comprising α, β, and γ subunits). The actual protein-conducting channel is the α-subunit encoded either by Sec61A1 or its paralog Sec61A2. Although the underlying channel selectivity for preproinsulin translocation is unknown, almost all studies of Sec61α to date have focused on Sec61α1. There is currently no evidence to suggest that this gene product plays a major role in proinsulin production, whereas genome-wide association studies indicate linkage of Sec61A2 with diabetes. Here, we report that evolutionary differences in mouse preproinsulin signal peptides affect proinsulin biosynthesis. Moreover, we find that, although some preproinsulin translocation can proceed through Sec61α1, Sec61α2 has a greater impact on proinsulin biosynthesis in pancreatic β-cells. Remarkably, Sec61α2 translocon deficiency exerts a significant inhibitory effect on the biosynthesis of preproinsulin itself, including a disproportionate increase of full-length nascent chain unreleased from ribosomes. This study not only reveals novel translocational regulation of proinsulin biosynthesis but also provides a rationale for genetic evidence suggesting an important role of Sec61α2 in maintaining blood glucose homeostasis. ARTICLE HIGHLIGHTS:

Indexed as

InsulinInsulin-Secreting CellsProinsulinSEC Translocation ChannelsAnimalsEndoplasmic ReticulumMembrane ProteinsMiceMice, KnockoutProtein PrecursorsProtein TransportInsulinMembrane ProteinspreproinsulinProinsulinProtein PrecursorsSEC Translocation Channels

Identifiers

PMID39325584
PMCPMC11579409

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.